Search research articles
Contact Us
Filters
Showing results (161-170 of 176) with videos related to
Page
of 18
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 2024
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer
Tongchen He, Caleb Cheng, Yuanyuan Qiao, et al.
Cancer
|
March 25, 2021
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)
Michael R Harrison, Brian A Costello, Nrupen A Bhavsar, et al.
Nature Genetics
|
October 3, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer
Jie Luo, Zhixiang Chen, Yuanyuan Qiao, et al.
Nature Communications
|
April 7, 2022
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial
Michiel S van der Heijden, Thomas Powles, Daniel Petrylak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2016
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
Lucia Nogova, Lecia V Sequist, Jose Manuel Perez Garcia, et al.
Clinical Genitourinary Cancer
|
March 23, 2017
Clinical Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced Penile Squamous-Cell Carcinoma: Results of a Multicenter Analysis
Andrea Necchi, Gregory R Pond, Daniele Raggi, et al.
European Urology
|
January 24, 2025
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types
Axel Bex, Michael Jewett, Bryan Lewis, et al.
Nature
|
December 23, 2021
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
Lanbo Xiao, Abhijit Parolia, Yuanyuan Qiao, et al.
Cancer Discovery
|
June 1, 2018
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with <i>FGFR3</i> Alterations
Sumanta K Pal, Jonathan E Rosenberg, Jean H Hoffman-Censits, et al.
Cancer
|
August 3, 2021
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement
Gennady Bratslavsky, Neil Mendhiratta, Michael Daneshvar, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 176) with videos related to
Sort By:
Page
of 18
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 2024
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer
Tongchen He, Caleb Cheng, Yuanyuan Qiao, et al.
Cancer
|
March 25, 2021
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)
Michael R Harrison, Brian A Costello, Nrupen A Bhavsar, et al.
Nature Genetics
|
October 3, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer
Jie Luo, Zhixiang Chen, Yuanyuan Qiao, et al.
Nature Communications
|
April 7, 2022
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial
Michiel S van der Heijden, Thomas Powles, Daniel Petrylak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2016
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
Lucia Nogova, Lecia V Sequist, Jose Manuel Perez Garcia, et al.
Clinical Genitourinary Cancer
|
March 23, 2017
Clinical Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced Penile Squamous-Cell Carcinoma: Results of a Multicenter Analysis
Andrea Necchi, Gregory R Pond, Daniele Raggi, et al.
European Urology
|
January 24, 2025
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types
Axel Bex, Michael Jewett, Bryan Lewis, et al.
Nature
|
December 23, 2021
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
Lanbo Xiao, Abhijit Parolia, Yuanyuan Qiao, et al.
Cancer Discovery
|
June 1, 2018
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with <i>FGFR3</i> Alterations
Sumanta K Pal, Jonathan E Rosenberg, Jean H Hoffman-Censits, et al.
Cancer
|
August 3, 2021
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement
Gennady Bratslavsky, Neil Mendhiratta, Michael Daneshvar, et al.
Page
of 18